OrganizationsBioAmber, Inc.

Products 11 to 12 of 12

Biotech components: Plant
Business models: B2B
Country of production: Canada
Country of distribution: Canada + France
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 14:32 (6 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input
Succinic Acid by Myriant + Royal DSM + BioAmber, Inc.
Biotech components: Molecule
Business models: B2C
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 14:37 (6 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Food & Agriculture + Health + Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Additive + Chemical + Personal Care (Topical)
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input